Shock Index More Sensitive Than Cardiogenic Shock in ST-Elevation Myocardial Infarction Treated by Primary

Veemal V Hemradj1, Jan Paul Ottervanger, Menko Jan de Boer

  • 1Department of Cardiology, Isala Heart Centre.

Insights

Shock index (SI) is a more sensitive predictor of mortality in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) than cardiogenic shock (CS). SI identifies more at-risk patients, improving risk stratification.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Prognostics

Background:

  • Cardiogenic shock (CS) is a known mortality predictor in ST-elevation myocardial infarction (STEMI).
  • Shock index (SI), calculated from blood pressure and heart rate, may offer improved predictive power.
  • The study investigates the independent prognostic value of SI versus CS in STEMI patients receiving primary percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To compare the independent impact of SI and CS on 30-day and 1-year mortality.
  • To determine if SI is a more sensitive predictor than CS in STEMI patients treated with primary PCI.

Main Methods:

  • Analysis of 7,412 consecutive STEMI patients treated with primary PCI.
  • Receiver operating characteristic (ROC) curve analysis to determine the optimal SI cut-off value.
  • Assessment of the predictive value of SI (cut-off 0.7) and CS for 1-year mortality using adjusted hazard ratios.

Main Results:

  • The optimal SI cut-off was 0.7, with an ROC AUC of 0.66, outperforming CS (ROC AUC 0.60, P<0.001).
  • At admission, 5.2% of patients had CS and 21.1% had SI ≥0.7.
  • Adjusted hazard ratios for 1-year mortality were 2.3 for SI ≥0.7 and 3.1 for CS.

Conclusions:

  • SI is a more sensitive prognostic predictor than CS in STEMI patients undergoing primary PCI.
  • SI identifies a larger proportion of patients at increased risk of mortality.
  • The findings support the use of SI for enhanced risk stratification in STEMI management.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
357
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
597
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
363
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.0K